Characteristic
|
Number (percentage)
|
DSS
|
DFS
|
---|
CHRa (95% CI)
|
p value
|
AHRb (95% CI)
|
p value
|
CHRa (95% CI)
|
p value
|
AHRb (95% CI)
|
p value
|
---|
IDH1 status
|
(n = 249)
| | | | | | | | |
High (5–7)
|
164 (65.9)
|
1.00
| |
1.00
| |
1.00
| |
1.00
| |
Low (0–4)
|
85 (34.1)
|
1.64 (1.14–2.38)
|
0.008
|
1.57 (1.08–2.30)
|
0.020
|
1.58 (1.07–2.34)
|
0.023
|
1.40 (0.93–2.10)
|
0.106
|
- Abbreviations: IDH isocitrate dehydrogenase, IDC invasive ductal carcinoma, DSS disease-specific survival, DFS disease-free survival, CHR crude hazard ratio, AHR adjusted hazard ratio
- aCHRs were estimated by univariate Cox regression
- bAHRs were adjusted for American Joint Committee on Cancer pathological stage (II and III vs. I), grading (III vs. I and II), incomplete or inappropriate adjuvant treatment vs. non-treatment or complete adjuvant treatment, and molecular subtypes (luminal B, human epidermal growth factor receptor 2 overexpression and basal-like vs. luminal A) in multivariate Cox regression
- Bold italic values denote statistically significant